Last edition
News about "biological pathways "
ModeX and Regeneron Partner to Develop Multispecific Antibodies
ModeX Therapeutics has entered into a research collaboration with Regeneron to develop multispecific antibodies capable of targeting multiple biological pathways within a single molecule. The partnership, valued at over USD 1 Billion, if multiple assets advance, aims to accelerate innovation across select therapeutic areas.
Biological Pathways | 30/10/2025 | By Dineshwori | 187
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members